Interleukin-22 protects intestinal stem cells against genotoxic stress

Nature

Volumn 566, Issue 7743, 2019, Pages 249-253

  Gronke, Konrad ^a,b,c,d,e,f   Hernández, Pedro P ^e,f,g   Zimmermann, Jakob ^e   Klose, Christoph S N ^a,e,h   Kofoed Branzk, Michael ^a,b,c,d,e,f   Guendel, Fabian ^a,b,c,d,e   Witkowski, Mario ^a,b,c,d   Tizian, Caroline ^a,b,c,d   Amann, Lukas ^e   Schumacher, Fabian ^i,j   Glatt, Hansruedi ^k,l   Triantafyllopoulou, Antigoni ^a,c   Diefenbach, Andreas ^a,b,c,d,e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BERLIN INSTITUTE OF HEALTH   (Germany)

^c DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

^f MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^g INSTITUT PASTEUR   (France)

^h WEILL CORNELL MEDICAL COLLEGE   (United States)

ⁱ UNIVERSITY OF POTSDAM   (Germany)

^j UNIVERSITY OF DUISBURG ESSEN   (Germany)

^k GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^l FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CARCINOGEN; GLUCOSINOLATE; INTERLEUKIN 22; INTERLEUKIN DERIVATIVE; INTERLEUKIN RECEPTOR; INTERLEUKIN-22; INTERLEUKIN-22 RECEPTOR; LIGAND; MUTAGENIC AGENT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL ACTIVATION; CELL PROTECTION; CELL STRESS; CELLULAR IMMUNITY; COLON CANCER; CONTROLLED STUDY; DNA DAMAGE RESPONSE; EMBRYO; GAMMA DELTA T LYMPHOCYTE; GENE MUTATION; GENOTOXICITY; IMMUNOCHEMISTRY; INTESTINAL STEM CELL; LETTER; LIGAND BINDING; LYMPHOID CELL; MALIGNANT TRANSFORMATION; METABOLITE; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SUPPRESSOR CELL; ANIMAL; APOPTOSIS; BIOSYNTHESIS; CELL TRANSFORMATION; COLON; COLON TUMOR; CYTOLOGY; DIET; DNA DAMAGE; DRUG EFFECT; GENETICS; INNATE IMMUNITY; INTESTINE MUCOSA; METABOLISM; MUTATION; STEM CELL; T LYMPHOCYTE;

MUS;

ANIMALS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; COLON; COLONIC NEOPLASMS; DIET; DNA DAMAGE; GLUCOSINOLATES; IMMUNITY, INNATE; INTERLEUKINS; INTESTINAL MUCOSA; LIGANDS; MICE; MUTAGENS; MUTATION; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, INTERLEUKIN; STEM CELLS; T-LYMPHOCYTES;

EID: 85061504994     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/s41586-019-0899-7     Document Type: Article

References (48)

1. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
2. Wu, S., Powers, S., Zhu, W. & Hannun, Y. A. Substantial contribution of extrinsic risk factors to cancer development. Nature 529, 43–47 (2016).
3. Blokzijl, F. et al. Tissue-specific mutation accumulation in human adult stem cells during life. Nature 538, 260–264 (2016).
4. Blanpain, C., Mohrin, M., Sotiropoulou, P. A. & Passegué, E. DNA-damage response in tissue-specific and cancer stem cells. Cell Stem Cell 8, 16–29 (2011).
5. Halazonetis, T. D., Gorgoulis, V. G. & Bartek, J. An oncogene-induced DNA damage model for cancer development. Science 319, 1352–1355 (2008).
6. Bjeldanes, L. F., Kim, J. Y., Grose, K. R., Bartholomew, J. C. & Bradfield, C. A. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc. Natl Acad. Sci. USA 88, 9543–9547 (1991).
7. Fu, D., Calvo, J. A. & Samson, L. D. Balancing repair and tolerance of DNA damage caused by alkylating agents. Nat. Rev. Cancer 12, 104–120 (2012).
8. Greten, F. R. et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118, 285–296 (2004).
9. Martincorena, I. et al. Universal patterns of selection in cancer and somatic tissues. Cell 171, 1029–1041 (2017).
10. Bailey, M. H. et al. Comprehensive characterization of cancer driver genes and mutations. Cell 173, 371–385 (2018).
11. Huber, S. et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 491, 259–263 (2012).
12. Lindemans, C. A. et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature 528, 560–564 (2015).
13. Zenewicz, L. A. et al. IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic. J. Immunol. 190, 5306–5312 (2013).
14. Barker, N. et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608–611 (2009).
15. Barker, N. et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003–1007 (2007).
16. Snippert, H. J. et al. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 143, 134–144 (2010).
17. + cells. Nat. Immunol. 10, 83–91 (2009).
18. Falck, J., Coates, J. & Jackson, S. P. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434, 605–611 (2005).
19. Barry, S. P. et al. STAT3 modulates the DNA damage response pathway. Int. J. Exp. Pathol. 91, 506–514 (2010).
20. Pickert, G. et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J. Exp. Med. 206, 1465–1472 (2009).
21. Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S. & Bonner, W. M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273, 5858–5868 (1998).
22. Fischer, M. Census and evaluation of p53 target genes. Oncogene 36, 3943–3956 (2017).
23. Merritt, A. J. et al. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res. 54, 614–617 (1994).
24. Qiu, W. et al. PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome. Cell Stem Cell 2, 576–583 (2008).
25. Hernandez, P., Gronke, K. & Diefenbach, A. A catch-22: interleukin-22 and cancer. Eur. J. Immunol. 48, 15–31 (2018).
26. Schumacher, F. et al. A secondary metabolite of Brassicales, 1-methoxy-3-indolylmethyl glucosinolate, as well as its degradation product, 1-methoxy-3-indolylmethyl alcohol, forms DNA adducts in the mouse, but in varying tissues and cells. Arch. Toxicol. 88, 823–836 (2014).
27. Kiss, E. A. et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334, 1561–1565 (2011).
28. Li, Y. et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147, 629–640 (2011).
29. Lee, J. S. et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 13, 144–151 (2011).
30. Metidji, A. et al. The environmental sensor AHR protects from inflammatory damage by maintaining intestinal stem cell homeostasis and barrier integrity. Immunity 49, 353–362 (2018).
31. + cells. Science 305, 248–251 (2004).
32. Kreymborg, K. et al. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J. Immunol. 179, 8098–8104 (2007).
33. Alonzi, T. et al. Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation in the liver. Mol. Cell. Biol. 21, 1621–1632 (2001).
34. El Marjou, F. et al. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 39, 186–193 (2004).
35. Schmidt, J. V., Su, G. H., Reddy, J. K., Simon, M. C. & Bradfield, C. A. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc. Natl Acad. Sci. USA 93, 6731–6736 (1996).
36. Walisser, J. A., Glover, E., Pande, K., Liss, A. L. & Bradfield, C. A. Aryl hydrocarbon receptor-dependent liver development and hepatotoxicity are mediated by different cell types. Proc. Natl Acad. Sci. USA 102, 17858–17863 (2005).
37. Skarnes, W. C. et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature 474, 337–342 (2011).
38. Farley, F. W., Soriano, P., Steffen, L. S. & Dymecki, S. M. Widespread recombinase expression using FLPeR (flipper) mice. Genesis 28, 106–110 (2000).
39. Gronke, K., Kofoed-Nielsen, M. & Diefenbach, A. Isolation and flow cytometry analysis of innate lymphoid cells from the intestinal lamina propria. Methods Mol. Biol. 1559, 255–265 (2017).
40. Cossarizza, A. et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies. Eur. J. Immunol. 47, 1584–1797 (2017).
41. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
42. Trapnell, C. et al. Transcript assembly and quantification by RNA-seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511–515 (2010).
43. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
44. Quaroni, A., Wands, J., Trelstad, R. L. & Isselbacher, K. J. Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria. J. Cell Biol. 80, 248–265 (1979).
45. Takahashi, M., Nakatsugi, S., Sugimura, T. & Wakabayashi, K. Frequent mutations of the β-catenin gene in mouse colon tumors induced by azoxymethane. Carcinogenesis 21, 1117–1120 (2000).
46. Schumacher, F., Herrmann, K., Florian, S., Engst, W. & Glatt, H. Optimized enzymatic hydrolysis of DNA for LC–MS/MS analyses of adducts of 1-methoxy-3-indolylmethyl glucosinolate and methyleugenol. Anal. Biochem. 434, 4–11 (2013).
47. Schumacher, F. et al. Detection of DNA adducts originating from 1-methoxy-3-indolylmethyl glucosinolate using isotope-dilution UPLC–ESI–MS/MS. Anal. Chem. 84, 6256–6262 (2012).
48. Speckmann, B. et al. Selenium increases hepatic DNA methylation and modulates one-carbon metabolism in the liver of mice. J. Nutr. Biochem. 48, 112–119 (2017).